MIRA CIK: 1904286

Mira Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
0.49
FY23:
4.86
FY24:
2.89
FY25:
11.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.36
FY23:
0.07
FY24:
0.04
FY25:
0.04
Total assets
Change from FY22 to FY25
millions USD
FY22:
0.86
FY23:
4.93
FY24:
2.92
FY25:
11.1

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
1.37
FY23:
0.56
FY24:
0.72
FY25:
0.70
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.08
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY22:
−0.60
FY23:
4.37
FY24:
2.20
FY25:
10.4
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
0.86
FY23:
4.93
FY24:
2.92
FY25:
11.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data